Home » Topics » BioWorld Science

BioWorld Science
RSS

Amicus and University of Pennsylvania expand gene therapy collaboration

May 30, 2019

NRF2 gene polymorphism tied to emphysema development in smokers

May 30, 2019

Michael J. Fox Foundation awards Casma Therapeutics grant to advance PD drug development

May 30, 2019

Merck & Co. discovers IDO1 inhibitors

May 30, 2019

Phase III KALM-1 study of Korsuva in hemodialysis patients with pruritus meets primary endpoint

May 30, 2019

Jubilant Biosys describes PD-1/PD-L1 interaction inhibitors

May 30, 2019

Metacrine reports phase Ib interim data on FXR agonist MET-409 in NASH

May 30, 2019

German researchers present new adenosine A2A receptor ligands

May 30, 2019

Xeomin approved in E.U. for treatment of chronic sialorrhea in adults

May 30, 2019

Sumitomo Dainippon Pharma patents TLR7 antagonists

May 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...